Pediatric Multiple Sclerosis with Primary Progressive Course—Report of a Retrospective Cohort Study in Iran

Abstract

The aims of this study were to suggest the rate of primary progressive (PP) subtype of pediatric onset multiple sclerosis (MS) in Isfahan, Iran, and describe its clinical and paraclinical features. The data of patients were retrieved from Isfahan MS Society (IMSS) database from April 2003 to August 2011. Among 3,843 MS patients of Isfahan who have been registered in IMSS, 260 patients had onset symptom when younger than the age of 18 years, of whom, 11 patients had a PP course (4.23%). The mean age at onset in pediatric primary progressive multiple sclerosis (PPMS) was 16 years (range: 13 to 17) with female preponderance (2.66:1) and disease duration of 4.73 ± 3.03 years. Ataxia was the most frequent initial symptom (7/11). Additionally, the mean Expanded Disability Status Scale and progression index was 4.31 ± 0.60 and 1.50 ± 1.21, respectively. Cerebrospinal fluid analysis showed oligoclonal immunoglobulin G bands in seven patients. Magnetic resonance imaging (MRI) demonstrated periventricular lesions in all 11 patients and spinal lesions in 9 patients. Exposure to parental smoking was recorded in seven individuals. In conclusion, PPMS is an uncommon subtype of pediatric onset MS. Cerebral lesions are more common MRI findings in pediatric PPMS patients than that in adults. The course of PPMS seems to be more progressive in the pediatric population than in adults.

Keywords

pediatric onset multiple sclerosis - primary progressive multiple sclerosis - Isfahan - Iran

• References

• 1 Krupp LB, Banwell B, Tenembaum S. International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68 (16) (Suppl. 02) S7-S12
• 2 Renoux C, Vukusic S, Mikaeloff Y , et al; Adult Neurology Departments KIDMUS Study Group. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007; 356 (25) 2603-2613
• 3 Polman CH, Reingold SC, Banwell B , et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69 (2) 292-302
• 4 Maghzi AH, Etemadifar M, Saadatnia M. Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran. Eur J Neurol 2007; 14 (4) 403-407
• 5 Thompson AJ, Polman CH, Miller DH , et al. Primary progressive multiple sclerosis. Brain 1997; 120 (Pt 6) 1085-1096
• 6 Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 6 (10) 887-902
• 7 Chitnis T, Krupp L, Yeh A , et al. Pediatric multiple sclerosis. Neurol Clin 2011; 29 (2) 481-505
• 8 Ness JM, Chabas D, Sadovnick AD, Pohl D, Banwell B, Weinstock-Guttman B. International Pediatric MS Study Group. Clinical features of children and adolescents with multiple sclerosis. Neurology 2007; 68 (16) (Suppl. 02) S37-S45
• 9 Andersson PB, Waubant E, Gee L, Goodkin DE. Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Arch Neurol 1999; 56 (9) 1138-1142
• 10 Etemadifar M, Nasr-Esfahani AH, Khodabandehlou R, Maghzi AH. Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran. Arch Iran Med 2007; 10 (2) 152-156
• 11 Mikaeloff Y, Caridade G, Tardieu M, Suissa S. KIDSEP study group. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 2007; 130 (Pt 10) 2589-2595